Braizon Therapeutics, Inc. is working to solve the blood brain barrier problem for oligonucleotide therapeutics, removing the need for spinal cord injections to treat neurological disorders.
Our Brain Access platform utilizes novel IP combining polymer nanoparticles with proven targeting methods for targeting therapies to the brain to create IV formulations for our partners. This platform is under development for expansion into small molecule, peptide, and antibody drug delivery into the brain.
HQ'd in Tokyo, Braizon has US operations in Cambridge, MA. enabling our experienced team to offer partnering worldwide for biotech and Pharma with a strategic focus on neurology.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3 Chome-42-1 Hongo, Bunkyo-Ku,
- Phone
- +81-3-5805-3417
- in****@****zon.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- braizon.com
- HQ
- Tokyo, Tokyo
Braizon Therapeutics, Inc. Questions
Braizon Therapeutics, Inc.'s helpline number is +81-3-5805-3417
Braizon Therapeutics, Inc.'s website is braizon.com
Braizon Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/braizon-therapeutics
Braizon Therapeutics, Inc. has
5 employees.
View email and phone details for 5
employees at Braizon Therapeutics, Inc..
Braizon Therapeutics, Inc.'s industry is
Biotechnology Research
Braizon Therapeutics, Inc.'s top competitors are
Therawin,
Stella Innovations Co., Ltd.,
Axonis Therapeutics,
Tagcyx Biotechnologies Inc.,
Sga Solar,
Dove Biotech Co., Ltd.,
Center On Disability Studies,
Sania Therapeutics,
Hawaii Data Science Institute,
University Of Hawaii - College Of Engineering.
Braizon Therapeutics, Inc.'s support email address is info@braizon.com
Braizon Therapeutics, Inc.'s categories are Biotechnology Research
Braizon Therapeutics, Inc.'s founding year is 2015
